BBVA USA’s Agilent Technologies A Stock Holding History

BBVA USA’s Portfolio A Stock Details A Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$2.93M	Sell	18,618 -922	-5%	-$149K	0.17%	128
2021 Q2	$2.89M	Buy	+19,540	New	+$2.67M	0.16%	133

Other funds holding A

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

BBVA USA's A Position: Q3 2021 in Review

BBVA USA reduced its Agilent Technologies (A) stake by 4.7% in Q3 2021, selling an estimated $149K and leaving 18,618 shares worth $2.93M. The position accounts for 0.17% of the portfolio, ranked #128.

BBVA USA first reported a position in A in Q2 2021 and has held it in 2 quarters since. 941 funds tracked by Wall St. Rank hold A as of Q3 2021.

BBVA USA held 18,618 shares of Agilent Technologies worth $2.93M as of Q3 2021.
BBVA USA sold 922 Agilent Technologies shares in Q3 2021, an estimated $149K.
Agilent Technologies made up 0.17% of BBVA USA's portfolio in Q3 2021, its #128 holding.
BBVA USA first reported a position in Agilent Technologies in Q2 2021 and has held it in 2 quarters since.
941 funds tracked by Wall St. Rank held Agilent Technologies as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.